The Friedrich Loeffler Institute in Germany has announced the successful testing of an experimental mRNA vaccine against foot-and-mouth disease (FMD), which could improve virus management. This vaccine uses fragments of the virus's genetic code, avoiding the need to manipulate live virus, making it safer. In tests, vaccinated cows showed no symptoms and shed less virus than unvaccinated cows. This is a significant achievement, given that foot-and-mouth disease severely affects animals but poses no risk to humans. Further studies are underway to approve the vaccine.
Sources
Cercetătorii germani au testat cu succes un vaccin pe bază de ARNm împotriva febrei aftoase
Cercetătorii germani au testat cu succes un vaccin pe bază de ARNm împotriva febrei aftoase
Cercetătorii germani au testat cu succes un vaccin împotriva febrei aftoase. Acesta folosește tehnologia ARNm
Cercetătorii germani au testat cu succes un vaccin pe bază de ARNm împotriva febrei aftoase
Latest News
09:10
Nicușor Dan, after Moody's decision: Romania must continue efforts to balance finances
08:48
Reactor 2 at Cernavodă is facing operational issues due to strong currents. Authorities are sinking barges to redirect the necessary water.
08:32
Russian attacks around Kyiv: Three dead, including a child
07:51
Devastating fire in Vâlcea: a man dead, a woman rescued
07:35
Bulgaria is facing a pronounced demographic decline, with the number of deaths exceeding births, despite a relatively high fertility rate.
See more news